title: Effectiveness of switching from oral ziprasidone to risperidone in a patient with comorbid autistic disorder, profound intellectual disability, Gilbert syndrome, and exacerbation of psychosis.
authors.affiliation: Department of Neurosciences, Mental Health, and Sensory Organs (NESMOS), School of Medicine and Psychology, Sapienza University; Unit of Psychiatry, Sant'Andrea Hospital, Via di Grottarossa 1035-1039, 00189 Rome, Italy, antonio.delcasale@uniroma1.it.
authors.forename: Antonio
authors.initials: A
authors.lastname: Del Casale
authors.forename: Georgios D
authors.initials: GD
authors.lastname: Kotzalidis
authors.forename: Michele
authors.initials: M
authors.lastname: Sacco
authors.forename: Chiara
authors.initials: C
authors.lastname: Rapinesi
authors.forename: Riccardo
authors.initials: R
authors.lastname: De Giorgi
authors.forename: Marco
authors.initials: M
authors.lastname: Giardini
authors.forename: Michele
authors.initials: M
authors.lastname: D'Andreagiovanni
authors.forename: Nicola
authors.initials: N
authors.lastname: Carlino
authors.forename: Roberto
authors.initials: R
authors.lastname: Brugnoli
authors.forename: Paolo
authors.initials: P
authors.lastname: Girardi
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D001321:Autistic Disorder / Q000188:drug therapy* / Q000453:epidemiology; D015897:Comorbidity; D005878:Gilbert Disease / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D008607:Intellectual Disability / Q000188:drug therapy* / Q000453:epidemiology; D008297:Male; D010879:Piperazines / Q000008:administration & dosage / Q000009:adverse effects*; D011618:Psychotic Disorders / Q000188:drug therapy* / Q000453:epidemiology; D018967:Risperidone / Q000008:administration & dosage / Q000494:pharmacology*; D013844:Thiazoles / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D014150:Antipsychotic Agents; D010879:Piperazines; D013844:Thiazoles; C092292:ziprasidone; D018967:Risperidone